Skip to main content
. 2018 Mar 10;8(3):197–204. doi: 10.1093/jpids/piy024

Table 2.

Baseline Factors for the Entire Cohort and for Patients With and Those Without an RVI

Characteristic Total Cohort (N = 1096) Patients With at Least 1 RVI or Influenza (n = 159) Patients Without an RVI or Influenza (n = 937) P
Age (median [IQR]) (years) 6.13 (1.43–13.7) 1.72 (0.73–4.46) 7.89 (1.68–14.09) <.001c
Sex, female (n [%]) 486 (44) 72 (45) 414 (44)
Race (n [%]) .11
 White 759 (69) 101 (64) 658 (70)
 Black 175 (16) 23 (14) 152 (16)
 Asian 32 (3) 9 (6) 23 (2)
 Native American 11 (1) 4 (2) 7 (1)
 Other/unknown 119 (11) 22 (14) 97 (11)
Transplant type (n [%])
 Heart 251 (23) 46 (29) 205 (22)
 Lung 66 (6) 11 (7) 55 (6)
 Liver 448 (41) 70 (44) 378 (40)
 Kidney 289 (26) 16 (10) 273 (29)
 Intestine 20 (2) 6 (4) 14 (2)
 Multiviscerala 22 (2) 10 (6) 12 (1)
Donor source (n [%])b .015c
 Living 191 (26) 13 (15) 178 (27)
 Deceased 546 (74) 73 (85) 473 (73)
Influenza vaccination .73
 Yes 571 (52) 10 (53) 561 (52)
 No 389 (36) 8 (42) 381 (35)
 Unknown 136 (12) 1 (5) 135 (13)
First transplant .20
 Yes 1026 (94) 145 (91) 881 (94)
 No 70 (6) 14 (9) 56 (6)

Abbreviations: RVI, respiratory virus infection; IQR, interquartile range.

aIncludes 2 heart–lung, 5 liver–intestines, and 15 liver and other organ transplants.

bLimited to liver and kidney transplants only.

cSignificant result.